Dermatological adverse events associated with use of oral mechanistic target of rapamycin inhibitors in a cohort of individuals with tuberous sclerosis complex

D. J. Pithadia, A. M. Treichel, A. M. Jones, P. Julien-Williams, T. Machado, J. Moss, T. N. Darling*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

1 Scopus citations
Original languageEnglish
Pages (from-to)588-589
Number of pages2
JournalBritish Journal of Dermatology
Volume183
Issue number3
DOIs
StatePublished - 1 Sep 2020

Cite this